FDA Inspection 1180709 — Transfusion Medicine Department Temple University Hospital
The FDA completed an inspection of Transfusion Medicine Department Temple University Hospital on Sep 27, 2022 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Philadelphia, PA (United States)